MR-guided, percutaneous microwave ablation of primary and secondary malignant tumors of liver and kidney

• Conditions: C64; D48.9; C22.9; Malignant neoplasm of kidney, except renal pelvis; Neoplasm of uncertain or unknown behaviour, unspecified; Liver, unspecified

• Registration Number: DRKS00017652
• Lead Sponsor: Abt. für Diagnostische und Interventionelle Radiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-30
• Study Completion: 2021-09-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

The study population includes patients undergoing MR-guided microwave ablation of primary or secondary liver or kidney tumors at the Institute of Diagnostic and Interventional Radiology (University hospital Tübingen).
Inclusion criteria are the age of 18 and the patient's legal capacity to consent.

Exclusion Criteria

Exclusion criterion is the patient's missing or incomplete declaration of consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of our prospective study is to investigate the long-term course (overall survival) of patients undergoing MR-guided microwave ablation of primary or secondary liver or kidney tumors in our department.

Secondary Outcome Measures

Name	Time	Method
relapse-free survival, <br>occurrence of local recurrences,<br>occurrence of complications